It appears to be new. There isn’t anything that looks edited together. Think we will be seeing a few more of these to manage the message after the hit letter from the FDA . It is apparent it put doubt out there in several countries based on NPs opening statements. Fortunately the Brazil trial will move forward and prove for the bureaucracies that this drug works..